Please login to the form below

Not currently logged in
Email:
Password:

Clinical

Amgen's Mvasi is first FDA-approved cancer biosimilar

Amgen's Mvasi is first FDA-approved cancer biosimilar

Offers prospect of lower-cost alternative to Roche's Avastin

Teva poaches Lundbeck's Schultz as new CEO

Teva poaches Lundbeck's Schultz as new CEO

Shares in Lundbeck fall as two senior posts become vacant

Prix Galien opens for entries with new award

Awards seen as highest accolade for innovation in life sciences

Novartis scores but Roche misses in melanoma trials

Novartis scores but Roche misses in melanoma trials

Phase III trial combo success for Tafinlar/Mekinist “unprecedented”

Lilly's abemaciclib data leaves potential uncertain

Lilly's abemaciclib data leaves potential uncertain

MONARCH 3 trial showed similar results to Pfizer’s Ibrance and Novartis’ Kisqali

More clinical news articles

reactivating drug research programmes

reactivating drug research programmes

Gene profiling technology offers new avenues for producing precision drugs

Rare diseases: meeting the challenge

Rare diseases: meeting the challenge

Problems with regulating orphan drugs

Japanese pharma pulls no punches with post-Brexit UK

Japanese pharma pulls no punches with post-Brexit UK

Firm want reassurance from the UK on its future in science and innovation

Brexit: Implications for the pharma industry

Brexit: Implications for the pharma industry

From patents to the EMA, data protection to clinical trials, there's a lot that should be a concern

Real-world evidence

Real-world evidence Investigating the sources of evidence as best practice moves from being knowledge-based to evidence-based

More clinical features

Featured jobs

Subscribe to our email news alerts

Latest intelligence

14_ipad_lowres.jpg
Why AI might be the rep’s best friend
When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...
How Transparent Is Transparency?
The second annual publication of transfer of value (TOV) data has just been publically disclosed. For those of you that it passed by, it seems to have generated very little...
Geraldine Murphy
LEO: Patients benefit from transparency
Paving the way for openness in pharma...

Infographics